|Other Names||Palmdelphin, Paralemmin-like protein, PALMD, C1orf11, PALML|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP13201a was selected from the N-term region of PALMD. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Cellular Location||Cytoplasm. Cell projection, dendrite. Cell projection, dendritic spine|
|Tissue Location||Ubiquitous. Most abundant in cardiac and skeletal muscle.|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
The specific function of this protein remains unknown.
Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010) :Vasan, R.S., et al. JAMA 302(2):168-178(2009)Olsen, J.V., et al. Cell 127(3):635-648(2006)Olsen, J.V., et al. Cell 127(3):635-648(2006)Ozyildirim, A.M., et al. Invest. Ophthalmol. Vis. Sci. 46(5):1572-1580(2005)
If you have any additional inquiries please email technical services at email@example.com.